Psychogeriatrics最新文献

英文中文

Risk factors of cognitive frailty in elderly chronic obstructive pulmonary disease patients and its implication for death: a cohort study 老年慢性阻塞性肺病患者认知能力衰弱的风险因素及其对死亡的影响：一项队列研究

IF 2 4区医学 Q3 GERIATRICS & GERONTOLOGY

Psychogeriatrics

Pub Date : 2023-12-29 DOI: 10.1111/psyg.13073

Xia Wu, Kehan Huang, Tingting Jiang, Huiqin Yu

Cognitive frailty, a clinical syndrome with physical frailty and cognitive impairment, leads to mortality and other adverse health outcomes in older adults. This study aimed to investigate the prevalence of cognitive frailty, and its influencing factors, and follow its impact on short-term mortality in elderly chronic obstructive pulmonary disease patients, to provide a theoretical scientific reference basis for clinical intervention and management of cognitive frailty.

认知功能虚弱是一种具有身体虚弱和认知功能障碍的临床综合征，会导致老年人的死亡率和其他不良健康结局。本研究旨在探讨认知虚弱的患病率及其影响因素，并追踪其对老年慢性阻塞性肺疾病患者短期死亡率的影响，为认知虚弱的临床干预和管理提供科学的理论参考依据。

引用次数: 0

Prevalence of sarcopenia and depressive symptoms among older adults: a scoping review 老年人肌肉疏松症和抑郁症状的患病率：范围界定综述

IF 2 4区医学 Q3 GERIATRICS & GERONTOLOGY

Psychogeriatrics

Pub Date : 2023-12-17 DOI: 10.1111/psyg.13060

Keerthana Sree Ganggaya, Divya Vanoh, Wan Rosli Wan Ishak

Sarcopenia causes a loss of skeletal muscle mass and decreases muscle strength and function. Depressive symptoms are a common cause of distress among geriatrics, significantly affecting the quality of life of older adults. Recently, studies have shown that a correlation exists between sarcopenia and depression. To determine the prevalence of sarcopenia and depressive symptoms and identify the factors associated with sarcopenia, we systematically searched the SCOPUS, Science Direct, and PubMed databases for papers on sarcopenia and depressive symptoms published from 2012 to 2022. We reviewed the literature on sarcopenia, depressive symptom prevalence, the prevalence of subjects with both sarcopenia and depressive symptoms, and the factors associated with sarcopenia. Only cross-sectional studies were included. Nineteen articles met the inclusion criteria for review, with overall sarcopenia prevalence ranging from 3.9% to 41.7%. The prevalence of depressive symptoms was reported in seven studies, ranging from 8.09% to 40%. The most commonly used tools to diagnose sarcopenia and depressive symptoms were the European Working Group on Sarcopenia in Older People consensus and the Geriatric Depression Scale, respectively. Being aged, malnourished, obese, having comorbidities (hypertension and diabetes), having impaired cognitive function, and having polypharmacy were found to be the factors associated with sarcopenia. Sarcopenia and depressive symptoms have been found to cause adverse health outcomes among older people. Appropriate nutritional assessments and interventions should be taken to manage these two geriatric conditions. Further studies should be planned, considering multidomain intervention strategies to improve sarcopenia and older people's mental health.

肌肉疏松症会导致骨骼肌质量下降，并降低肌肉力量和功能。抑郁症状是老年病患者的常见病因，严重影响老年人的生活质量。最近有研究表明，肌肉疏松症与抑郁症之间存在相关性。为了确定肌肉疏松症和抑郁症状的发病率，并找出与肌肉疏松症相关的因素，我们系统地检索了 SCOPUS、Science Direct 和 PubMed 数据库中 2012 年至 2022 年发表的有关肌肉疏松症和抑郁症状的论文。我们回顾了有关肌肉疏松症、抑郁症状患病率、同时患有肌肉疏松症和抑郁症状的受试者患病率以及与肌肉疏松症相关因素的文献。仅纳入了横断面研究。有 19 篇文章符合纳入审查的标准，总体肌肉疏松症发病率介于 3.9% 与 41.7% 之间。有七项研究报告了抑郁症状的发生率，从 8.09% 到 40% 不等。最常用于诊断肌肉疏松症和抑郁症状的工具分别是欧洲老年人肌肉疏松症工作组共识和老年抑郁量表。研究发现，高龄、营养不良、肥胖、合并症（高血压和糖尿病）、认知功能受损和使用多种药物是与肌肉疏松症相关的因素。研究发现，肌肉疏松症和抑郁症状会对老年人的健康造成不利影响。应采取适当的营养评估和干预措施来控制这两种老年病。应计划开展进一步研究，考虑采取多领域干预策略，以改善肌肉疏松症和老年人的心理健康。

{"title":"Prevalence of sarcopenia and depressive symptoms among older adults: a scoping review","authors":"Keerthana Sree Ganggaya, Divya Vanoh, Wan Rosli Wan Ishak","doi":"10.1111/psyg.13060","DOIUrl":"https://doi.org/10.1111/psyg.13060","url":null,"abstract":"Sarcopenia causes a loss of skeletal muscle mass and decreases muscle strength and function. Depressive symptoms are a common cause of distress among geriatrics, significantly affecting the quality of life of older adults. Recently, studies have shown that a correlation exists between sarcopenia and depression. To determine the prevalence of sarcopenia and depressive symptoms and identify the factors associated with sarcopenia, we systematically searched the SCOPUS, Science Direct, and PubMed databases for papers on sarcopenia and depressive symptoms published from 2012 to 2022. We reviewed the literature on sarcopenia, depressive symptom prevalence, the prevalence of subjects with both sarcopenia and depressive symptoms, and the factors associated with sarcopenia. Only cross-sectional studies were included. Nineteen articles met the inclusion criteria for review, with overall sarcopenia prevalence ranging from 3.9% to 41.7%. The prevalence of depressive symptoms was reported in seven studies, ranging from 8.09% to 40%. The most commonly used tools to diagnose sarcopenia and depressive symptoms were the European Working Group on Sarcopenia in Older People consensus and the Geriatric Depression Scale, respectively. Being aged, malnourished, obese, having comorbidities (hypertension and diabetes), having impaired cognitive function, and having polypharmacy were found to be the factors associated with sarcopenia. Sarcopenia and depressive symptoms have been found to cause adverse health outcomes among older people. Appropriate nutritional assessments and interventions should be taken to manage these two geriatric conditions. Further studies should be planned, considering multidomain intervention strategies to improve sarcopenia and older people's mental health.","PeriodicalId":20784,"journal":{"name":"Psychogeriatrics","volume":"28 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2023-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138714817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Joint associations of sleep duration and physical activity with cognitive impairment among rural elderly over 65 years old: a cross-sectional study 睡眠时间和体力活动与 65 岁以上农村老年人认知障碍的共同关系：一项横断面研究

IF 2 4区医学 Q3 GERIATRICS & GERONTOLOGY

Psychogeriatrics

Pub Date : 2023-12-14 DOI: 10.1111/psyg.13056

Jie Wu, Chenchen Wang, Shengxiang Qi, Zhenzhen Qin, Hao Xu, Xin Hong

During the long preclinical phase of dementia, accelerated cognitive impairment is regarded as a cardinal marker. Thus, the identification of risk factors for cognitive impairment is of great significance for dementia prevention. This study aims to examine the joint associations of sleep duration and physical activity with cognitive impairment among rural elderly over 65 years old, and provide suggestions for improving the cognitive function in rural elderly over 65 years old.

在痴呆症漫长的临床前期阶段，认知功能加速受损被视为一个主要标志。因此，识别认知障碍的危险因素对预防痴呆症具有重要意义。本研究旨在探讨睡眠时间和体力活动与 65 岁以上农村老年人认知功能障碍的关系，并为改善 65 岁以上农村老年人的认知功能提供建议。

引用次数: 0

Factors associated with reduced sleep among spouses and caregivers of older adults with varying levels of cognitive decline 与认知能力下降程度不同的老年人的配偶和照顾者睡眠减少有关的因素

IF 2 4区医学 Q3 GERIATRICS & GERONTOLOGY

Psychogeriatrics

Pub Date : 2023-12-14 DOI: 10.1111/psyg.13064

Virginia T. Gallagher, Shannon E. Reilly, M. Agustina Rossetti, Meghan Mattos, Carol Manning

Caregivers of persons with cognitive decline (PWCD) are at increased risk of poor sleep quantity and quality. It is unclear whether this is due to factors in the caregiver versus in the PWCD.

认知能力下降患者（PWCD）的照顾者睡眠数量和质量不佳的风险增加。目前还不清楚这是由于护理者的因素还是认知功能减退者的因素造成的。

引用次数: 0

A case of folate deficiency showing behavioural variant of frontotemporal dementia‐like symptoms 一例叶酸缺乏症患者表现出行为变异的额颞叶痴呆样症状

IF 2 4区医学 Q3 GERIATRICS & GERONTOLOGY

Psychogeriatrics

Pub Date : 2023-12-09 DOI: 10.1111/psyg.13055

Arisa Fujii, A. Ikenouchi, Naomichi Okamoto, Rintaro Fujii, Satoru Ide, Reiji Yoshimura

引用次数: 0

Issue Information 问题信息

IF 2 4区医学 Q3 GERIATRICS & GERONTOLOGY

Psychogeriatrics

Pub Date : 2023-07-01 DOI: 10.1111/psyg.12853

引用次数: 0

Issue Information 问题信息

IF 2 4区医学 Q3 GERIATRICS & GERONTOLOGY

Psychogeriatrics

Pub Date : 2023-05-01 DOI: 10.1111/psyg.12852

引用次数: 0

Issue Information 问题信息

IF 2 4区医学 Q3 GERIATRICS & GERONTOLOGY

Psychogeriatrics

Pub Date : 2023-01-01 DOI: 10.1002/jsc.2504

引用次数: 0

Issue Information 问题信息

IF 2 4区医学 Q3 GERIATRICS & GERONTOLOGY

Psychogeriatrics

Pub Date : 2022-10-31 DOI: 10.1111/psyg.12718

引用次数: 0

Comparison of Rapid Cognitive Screen against Montreal Cognitive Assessment in screening for cognitive impairment in the old and old-old. 快速认知筛查与蒙特利尔认知评估在老年人和老年认知障碍筛查中的比较

IF 1.7 4区医学 Q3 GERIATRICS & GERONTOLOGY

Psychogeriatrics

Pub Date : 2022-07-01 Epub Date: 2022-05-16 DOI: 10.1111/psyg.12841

Matthew Zhixuan Chen, Yiong Huak Chan, Michael Wai Kit Wong, Reshma Aziz Merchant

Background: The Montreal Cognitive Assessment (MoCA) was developed as a screening tool for mild cognitive impairment (MCI). Given the need for a rapid screening test in settings such as primary care, we compare the validity of the Rapid Cognitive Screen (RCS) against the MoCA, and determine cut-off scores in the old and old-old.

Methods: Cross-sectional study involving community-dwelling 'old' (65 to 79 years old) and 'old-old' (≥ 80 years old) without dementia. Cognitive impairment was defined by MoCA score 17 to 22. Validation was done using the receiver operating characteristic (ROC) curve analysis: area under the curve (AUC), sensitivity (Sn), and specificity (Sp).

Results: Of the 183 participants (mean age 72.1 ± 5.2 years),15.8% (n = 29) were classified as cognitively impaired. The overall ROC curve had an AUC of 0.82 (95% CI 0.75-0.90, P < 0.01) with an optimal cut-off of 7/8 on RCS (Sn 0.77, Sp 0.72). The 'old' and 'old-old' group had AUC of 0.82 (95% CI 0.74-0.91, P < 0.01) with 8/9 as optimal cut-off (Sn 0.51, Sp 0.96) and AUC of 0.85 (95% CI 0.66-1.03, P < 0.01) with 7/8 as optimal cut-off (Sn 0.71, Sp 1.00) respectively. In multivariate analysis, age was associated with 0.05 (95% CI -0.10-0.00, P < 0.04) point decrement, while >6 years of education was associated with 0.82 (95% CI 0.32-1.33, P < 0.01) point increment in RCS scores.

Conclusion: The three-item RCS is quick and easy to administer. Although RCS met the criterion for good validity against MoCA in predicting cognitive impairment, its utility as a first-line screening tool needs to be further validated in a large-scale population study.

蒙特利尔认知评估（MoCA）是作为轻度认知障碍（MCI）的筛查工具而开发的。考虑到在初级保健等环境中需要进行快速筛查测试，我们将快速认知筛查（RCS）的有效性与MoCA进行了比较，并确定了老年人和老年人的截断分数。

{"title":"Comparison of Rapid Cognitive Screen against Montreal Cognitive Assessment in screening for cognitive impairment in the old and old-old.","authors":"Matthew Zhixuan Chen, Yiong Huak Chan, Michael Wai Kit Wong, Reshma Aziz Merchant","doi":"10.1111/psyg.12841","DOIUrl":"10.1111/psyg.12841","url":null,"abstract":"Background: The Montreal Cognitive Assessment (MoCA) was developed as a screening tool for mild cognitive impairment (MCI). Given the need for a rapid screening test in settings such as primary care, we compare the validity of the Rapid Cognitive Screen (RCS) against the MoCA, and determine cut-off scores in the old and old-old.Methods: Cross-sectional study involving community-dwelling 'old' (65 to 79 years old) and 'old-old' (≥ 80 years old) without dementia. Cognitive impairment was defined by MoCA score 17 to 22. Validation was done using the receiver operating characteristic (ROC) curve analysis: area under the curve (AUC), sensitivity (Sn), and specificity (Sp).Results: Of the 183 participants (mean age 72.1 ± 5.2 years),15.8% (n = 29) were classified as cognitively impaired. The overall ROC curve had an AUC of 0.82 (95% CI 0.75-0.90, P < 0.01) with an optimal cut-off of 7/8 on RCS (Sn 0.77, Sp 0.72). The 'old' and 'old-old' group had AUC of 0.82 (95% CI 0.74-0.91, P < 0.01) with 8/9 as optimal cut-off (Sn 0.51, Sp 0.96) and AUC of 0.85 (95% CI 0.66-1.03, P < 0.01) with 7/8 as optimal cut-off (Sn 0.71, Sp 1.00) respectively. In multivariate analysis, age was associated with 0.05 (95% CI -0.10-0.00, P < 0.04) point decrement, while >6 years of education was associated with 0.82 (95% CI 0.32-1.33, P < 0.01) point increment in RCS scores.Conclusion: The three-item RCS is quick and easy to administer. Although RCS met the criterion for good validity against MoCA in predicting cognitive impairment, its utility as a first-line screening tool needs to be further validated in a large-scale population study.","PeriodicalId":20784,"journal":{"name":"Psychogeriatrics","volume":"22 1","pages":"460-468"},"PeriodicalIF":1.7,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45327015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Psychogeriatrics

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀